{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T11:22:21Z","timestamp":1774437741343,"version":"3.50.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T00:00:00Z","timestamp":1681344000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005788","name":"Medizinische Universit\u00e4t Wien","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.trsl.2023.04.001","type":"journal-article","created":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T11:56:19Z","timestamp":1681300579000},"page":"28-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Computational drug repositioning of clopidogrel as a novel therapeutic option for focal segmental glomerulosclerosis"],"prefix":"10.1016","volume":"259","author":[{"given":"Christoph A.","family":"Gebeshuber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Daniel-Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinz","family":"Regele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helga","family":"Schachner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Aufricht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Kornauth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Ley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seth L.","family":"Alper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Kratochwill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Perco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.trsl.2023.04.001_bib0001","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1053\/snep.2003.50012","article-title":"Pathologic classification of focal segmental glomerulosclerosis","volume":"23","author":"D'Agati","year":"2003","journal-title":"Semin Nephrol"},{"issue":"10","key":"10.1016\/j.trsl.2023.04.001_bib0002","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nrneph.2013.169","article-title":"The podocyte slit diaphragm\u2013from a thin grey line to a complex signalling hub","volume":"9","author":"Grahammer","year":"2013","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"10.1016\/j.trsl.2023.04.001_bib0003","doi-asserted-by":"crossref","first-page":"626","DOI":"10.2215\/CJN.05810513","article-title":"Glomerular diseases: FSGS","volume":"9","author":"Bose","year":"2014","journal-title":"Clin J Am Soc Nephrol CJASN"},{"issue":"3","key":"10.1016\/j.trsl.2023.04.001_bib0004","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2215\/CJN.05960616","article-title":"Focal segmental glomerulosclerosis","volume":"12","author":"Rosenberg","year":"2017","journal-title":"Clin J Am Soc Nephrol CJASN"},{"issue":"9","key":"10.1016\/j.trsl.2023.04.001_bib0005","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/s41581-021-00427-1","article-title":"Therapeutic trials in adult FSGS: lessons learned and the road forward","volume":"17","author":"De Vriese","year":"2021","journal-title":"Nat Rev Nephrol"},{"issue":"10","key":"10.1016\/j.trsl.2023.04.001_bib0006","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1016\/j.ekir.2021.07.030","article-title":"A retrospective study of clinical and economic burden of focal segmental glomerulosclerosis (FSGS) in the United States","volume":"6","author":"Kalantar-Zadeh","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"3","key":"10.1016\/j.trsl.2023.04.001_bib0007","first-page":"E61","article-title":"Proximal pathway enrichment analysis for targeting comorbid diseases via network endopharmacology","volume":"11","author":"Aguirre-Plans","year":"2018","journal-title":"Pharm Basel Switz"},{"issue":"1","key":"10.1016\/j.trsl.2023.04.001_bib0008","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41572-020-0196-7","article-title":"Podocytopathies","volume":"6","author":"Kopp","year":"2020","journal-title":"Nat Rev Dis Primer"},{"issue":"11","key":"10.1016\/j.trsl.2023.04.001_bib0009","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1093\/ndt\/gfv355","article-title":"Genetic testing in steroid-resistant nephrotic syndrome: when and how?","volume":"31","author":"Lovric","year":"2016","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"10.1016\/j.trsl.2023.04.001_bib0010","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1007\/s00125-019-4859-4","article-title":"Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease","volume":"62","author":"Heerspink","year":"2019","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.trsl.2023.04.001_bib0011","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2174\/1381612822666161006153639","article-title":"Predictive biomarkers for linking disease pathology and drug effect","volume":"23","author":"Mayer","year":"2017","journal-title":"Curr Pharm Des"},{"issue":"3","key":"10.1016\/j.trsl.2023.04.001_bib0012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214332","article-title":"A systems pharmacology workflow with experimental validation to assess the potential of anakinra for treatment of focal and segmental glomerulosclerosis","volume":"14","author":"Boehm","year":"2019","journal-title":"PloS One"},{"issue":"02","key":"10.1016\/j.trsl.2023.04.001_bib0013","first-page":"073","article-title":"Using information content for expanding human protein coding gene interaction networks","volume":"06","author":"Fechete","year":"2013","journal-title":"J Comput Sci Syst Biol"},{"key":"10.1016\/j.trsl.2023.04.001_bib0014","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2105-4-2","article-title":"An automated method for finding molecular complexes in large protein interaction networks","volume":"4","author":"Bader","year":"2003","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.trsl.2023.04.001_bib0015","doi-asserted-by":"crossref","unstructured":"BT Sherman, M Hao, J Qiu, et al., DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update), Nucleic Acids Res, 2022,2022 Jul 5;50(W1):W216-W221. doi: 10.1093\/nar\/gkac194.","DOI":"10.1093\/nar\/gkac194"},{"issue":"D1","key":"10.1016\/j.trsl.2023.04.001_bib0016","doi-asserted-by":"crossref","first-page":"D687","DOI":"10.1093\/nar\/gkab1028","article-title":"The reactome pathway knowledgebase 2022","volume":"50","author":"Gillespie","year":"2022","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"10.1016\/j.trsl.2023.04.001_bib0017","doi-asserted-by":"crossref","first-page":"D613","DOI":"10.1093\/nar\/gkaa1024","article-title":"WikiPathways: connecting communities","volume":"49","author":"Martens","year":"2021","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"10.1016\/j.trsl.2023.04.001_bib0018","doi-asserted-by":"crossref","first-page":"D325","DOI":"10.1093\/nar\/gkaa1113","article-title":"The gene ontology resource: enriching a GOld mine","volume":"49","year":"2021","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"10.1016\/j.trsl.2023.04.001_bib0019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218934","article-title":"Ticagrelor induces paraoxonase-1 (PON1) and better protects hypercholesterolemic mice against atherosclerosis compared to clopidogrel","volume":"14","author":"Halim","year":"2019","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.trsl.2023.04.001_bib0020","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1440-1797.2010.01383.x","article-title":"Adriamycin nephropathy: a model of focal segmental glomerulosclerosis","volume":"16","author":"Lee","year":"2011","journal-title":"Nephrol Carlton Vic"},{"key":"10.1016\/j.trsl.2023.04.001_bib0021","unstructured":"CJ Beavers and IA Naqvi, Clopidogrel, StatPearls [Internet], 2022, StatPearls Publishing; Treasure Island (FL), [cited 2022 May 18]. Available at: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK470539\/. September 2022."},{"issue":"1","key":"10.1016\/j.trsl.2023.04.001_bib0022","doi-asserted-by":"crossref","first-page":"239","DOI":"10.7150\/ijbs.29063","article-title":"Clopidogrel reduces fibronectin accumulation and improves diabetes-induced renal fibrosis","volume":"15","author":"Zheng","year":"2019","journal-title":"Int J Biol Sci"},{"issue":"10","key":"10.1016\/j.trsl.2023.04.001_bib0023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0259129","article-title":"Drug repositioning of Clopidogrel or Triamterene to inhibit influenza virus replication in vitro","volume":"16","author":"Orr-Burks","year":"2021","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.trsl.2023.04.001_bib0024","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/ddr.21640","article-title":"Selected pharmacotherapy agents as antiproliferative and anti-inflammatory compounds","volume":"81","author":"AlKhalil","year":"2020","journal-title":"Drug Dev Res"},{"issue":"6","key":"10.1016\/j.trsl.2023.04.001_bib0025","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1111\/j.1523-1755.2004.00630.x","article-title":"Platelet inhibition limits TGF-beta overexpression and matrix expansion after induction of anti-thy1 glomerulonephritis","volume":"65","author":"Peters","year":"2004","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.trsl.2023.04.001_bib0026","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1681\/ASN.2007020160","article-title":"Anti-inflammatory renoprotective effect of clopidogrel and irbesartan in chronic renal injury","volume":"19","author":"Tu","year":"2008","journal-title":"J Am Soc Nephrol JASN"},{"issue":"5","key":"10.1016\/j.trsl.2023.04.001_bib0027","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1046\/j.1523-1755.2003.00288.x","article-title":"Activation of the TGF-beta\/Smad signaling pathway in focal segmental glomerulosclerosis","volume":"64","author":"Kim","year":"2003","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.trsl.2023.04.001_bib0028","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1159\/000106775","article-title":"Laser capture microdissection-microarray analysis of focal segmental glomerulosclerosis glomeruli","volume":"107","author":"Bennett","year":"2007","journal-title":"Nephron Exp Nephrol"},{"issue":"6","key":"10.1016\/j.trsl.2023.04.001_bib0029","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1172\/JCI200112367","article-title":"Apoptosis in podocytes induced by TGF-beta and Smad7","volume":"108","author":"Schiffer","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2023.04.001_bib0030","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/978-981-13-8871-2_16","article-title":"TGF-\u03b2\/Smad and renal fibrosis","volume":"1165","author":"Ma","year":"2019","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"10.1016\/j.trsl.2023.04.001_bib0031","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.thromres.2008.04.017","article-title":"Clopidogrel pretreatment abolishes increase of PAI-1 after coronary stent implantation","volume":"123","author":"Katsaros","year":"2008","journal-title":"Thromb Res"},{"issue":"6","key":"10.1016\/j.trsl.2023.04.001_bib0032","doi-asserted-by":"crossref","first-page":"E2095","DOI":"10.3390\/ijms21062095","article-title":"ECM characterization reveals a massive activation of acute phase response during FSGS","volume":"21","author":"Bukosza","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.trsl.2023.04.001_bib0033","doi-asserted-by":"crossref","first-page":"F619","DOI":"10.1152\/ajprenal.00444.2013","article-title":"Clopidogrel preserves whole kidney autoregulatory behavior in ANG II-induced hypertension","volume":"306","author":"Osmond","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"10.1016\/j.trsl.2023.04.001_bib0034","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/09537104.2021.1883574","article-title":"Antiplatelet drugs and liver fibrosis","volume":"33","author":"Czajka","year":"2022","journal-title":"Platelets"},{"key":"10.1016\/j.trsl.2023.04.001_bib0035","article-title":"Bioinformatic analysis combined with experimental validation reveals novel hub genes and pathways associated with focal segmental glomerulosclerosis","volume":"8","author":"Hou","year":"2021","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.trsl.2023.04.001_bib0036","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9128050","article-title":"Clopidogrel protects endothelium by hindering TNF\u03b1-Induced VCAM-1 expression through CaMKK\u03b2\/AMPK\/Nrf2 Pathway","volume":"2016","author":"Yang","year":"2016","journal-title":"J Diabetes Res"},{"issue":"1","key":"10.1016\/j.trsl.2023.04.001_bib0037","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/s12872-019-01287-1","article-title":"Ticagrelor and clopidogrel suppress NF-\u03baB signaling pathway to alleviate LPS-induced dysfunction in vein endothelial cells","volume":"19","author":"Jia","year":"2019","journal-title":"BMC Cardiovasc Disord"},{"issue":"19","key":"10.1016\/j.trsl.2023.04.001_bib0038","doi-asserted-by":"crossref","first-page":"10330","DOI":"10.3390\/ijms221910330","article-title":"Platelet inhibition prevents NLRP3 Inflammasome activation and sepsis-induced kidney injury","volume":"22","author":"Borges-Rodriguez","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.trsl.2023.04.001_bib0039","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.carrev.2016.01.010","article-title":"Inhibition of platelet function with clopidogrel is associated with a reduction of inflammation in patients with peripheral artery disease","volume":"17","author":"Meyer","year":"2016","journal-title":"Cardiovasc Revascularization Med Mol Interv"},{"issue":"5","key":"10.1016\/j.trsl.2023.04.001_bib0040","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.clpt.2005.08.002","article-title":"Anti-inflammatory effects of clopidogrel intake in renal transplant patients: effects on platelet-leukocyte interactions, platelet CD40 ligand expression, and proinflammatory biomarkers","volume":"78","author":"Graff","year":"2005","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.trsl.2023.04.001_bib0041","doi-asserted-by":"crossref","first-page":"13750","DOI":"10.1096\/fj.202000897R","article-title":"Platelet inhibition by ticagrelor is protective against diabetic nephropathy in mice","volume":"34","author":"Uil","year":"2020","journal-title":"FASEB J"},{"issue":"6","key":"10.1016\/j.trsl.2023.04.001_bib0042","doi-asserted-by":"crossref","first-page":"eaav5463","DOI":"10.1126\/sciadv.aav5463","article-title":"Targeting thrombogenicity and inflammation in chronic HIV infection","volume":"5","author":"O'Brien","year":"2019","journal-title":"Sci Adv"},{"issue":"2","key":"10.1016\/j.trsl.2023.04.001_bib0043","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/MNH.0b013e328335f91f","article-title":"Endothelin, hypertension and chronic kidney disease: new insights","volume":"19","author":"Kohan","year":"2010","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"2","key":"10.1016\/j.trsl.2023.04.001_bib0044","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/path.2916","article-title":"Clopidogrel protects from cell apoptosis and oxidative damage in a mouse model of renal ischaemia-reperfusion injury","volume":"225","author":"Hu","year":"2011","journal-title":"J Pathol"},{"issue":"19","key":"10.1016\/j.trsl.2023.04.001_bib0045","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.150004","article-title":"AMPK mediates regulation of glomerular volume and podocyte survival","volume":"6","author":"Banu","year":"2021","journal-title":"JCI Insight"},{"issue":"7","key":"10.1016\/j.trsl.2023.04.001_bib0046","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.ekir.2021.04.023","article-title":"Chronic inflammation in chronic kidney disease progression: role of Nrf2","volume":"6","author":"Stenvinkel","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"9","key":"10.1016\/j.trsl.2023.04.001_bib0047","doi-asserted-by":"crossref","first-page":"e74871","DOI":"10.1371\/journal.pone.0074871","article-title":"Citral is renoprotective for focal segmental glomerulosclerosis by inhibiting oxidative stress and apoptosis and activating Nrf2 pathway in mice","volume":"8","author":"Yang","year":"2013","journal-title":"PloS One"},{"issue":"9","key":"10.1016\/j.trsl.2023.04.001_bib0048","first-page":"547","article-title":"The activation of high mobility group Box1 and toll-like receptor 4 is involved in clopidogrel-induced gastric injury through p38 MAPK","volume":"74","author":"Jiang","year":"2019","journal-title":"Pharm"},{"issue":"5","key":"10.1016\/j.trsl.2023.04.001_bib0049","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/nep.13046","article-title":"Fibrinogen links podocyte injury with Toll-like receptor 4 and is associated with disease activity in FSGS patients","volume":"23","author":"Wang","year":"2018","journal-title":"Nephrol Carlton Vic"},{"issue":"8","key":"10.1016\/j.trsl.2023.04.001_bib0050","doi-asserted-by":"crossref","first-page":"600","DOI":"10.4239\/wjd.v13.i8.600","article-title":"Clopidogrel delays and can reverse diabetic nephropathy pathogenesis in type 2 diabetic db\/db mice","volume":"13","author":"Li","year":"2022","journal-title":"World J Diabetes"},{"issue":"2","key":"10.1016\/j.trsl.2023.04.001_bib0051","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.2042-7158.2012.01567.x","article-title":"Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems","volume":"65","author":"Tacar","year":"2013","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.trsl.2023.04.001_bib0052","article-title":"Antiplatelet agents for chronic kidney disease","volume":"2","author":"Natale","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.trsl.2023.04.001_bib0053","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1681\/ASN.2018010091","article-title":"DUET: a phase 2 study evaluating the efficacy and safety of Sparsentan in patients with FSGS","volume":"29","author":"Trachtman","year":"2018","journal-title":"J Am Soc Nephrol JASN"},{"issue":"1","key":"10.1016\/j.trsl.2023.04.001_bib0054","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13023-018-0931-2","article-title":"Recommendations for the design of small population clinical trials","volume":"13","author":"Day","year":"2018","journal-title":"Orphanet J Rare Dis"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524423000579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524423000579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T12:48:08Z","timestamp":1761828488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524423000579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":54,"alternative-id":["S1931524423000579"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2023.04.001","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Computational drug repositioning of clopidogrel as a novel therapeutic option for focal segmental glomerulosclerosis","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2023.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}